Evrys Bio

Exciting Sirtuin 2 publication by the Evrys Team regarding the broad-spectrum antiinfective activity of this mechanism. #SIRT2 https://lnkd.in/dZd-c7ju

Congratulations to Stacy Remiszewski, Ph.D. on his presentation "The Allosteric Sirtuin 2 Modulator FLS-359 Inhibits Viral Replication" at the recent American Chemical Society Congress in Denver Colorado #ACS2024. Evrys Bio showcasing its cutting edge science. #hosttargetedantiviral https://lnkd.in/ehX_Epry

Exciting job opportunity at Evrys Bio https://lnkd.in/e3v8a8Pe Sr. Director of Project Management (Preclinical to FIH)

Thrilling update from Louis Kassa in today's Philadelphia Business Journal! Having served as CEO since July 2022, Lou applauds the achievements of the Academic Innovation Zone (AIZ) program, deeming it a standout success during his 10-year leadership. But there is still more to be done in attracting funding for the Greater Philadelphia Region. The AIZ program, supported by a $5 million grant from the Pennsylvania Department of Health, has already benefited 11 companies, creating over 20 new jobs with potential for more. Lou is seeking additional state support to continue this impactful program. The AIZ program provides funding, lab space, supplies, and staffing help to early-stage life sciences companies at the Pennsylvania Biotechnology Center in Doylestown and B?labs in Ucity life sciences incubators. The goal is to attract and retain life sciences companies in Pennsylvania. With more funding, Lou aims to scale up the program, supporting more companies and bringing academic innovations to life. In the spirit of collaboration, Lou expresses hope that the huge success of the AIZ program can influence Office of Governor Josh Shapiro and the Pennsylvania State House to consider a larger investment in the state. Let's work together to amplify the positive impact of this initiative and propel Philadelphia and Pennsylvania to the forefront of life sciences innovation! Investments to date: >>Serna Bio - $500,000 (B+Labs) >>Stealth Mode - $500,000 (B+Labs) >>APREA THERAPEUTICS AB - $250,000 (PABC) >>Virion Therapeutics, LLC - $250,000 (PABC) >>Evrys Bio - $250,000 (PABC) >>Eliksa Therapeutics - $150,000 + Fee Lab (PABC) >>Merlin Biotech - $100,000 >>Synergy Therapeutics - Free Labs (PABC) >>Nous and Young Therapeutics - Free Labs (PABC)